Open innovation: A real option to restore value to the biopharmaceutical R&D

GL Nigro, A Morreale, G Enea - International Journal of Production …, 2014 - Elsevier
The pharmaceutical landscape has changed, and new business models, based on
alliances, are increasingly being adopted in this industry. Biotechnology advances have …

[PDF][PDF] A real options based support system to open innovation

GL Nigro, A Morreale - ISPIM Conference Proceedings, 2012 - core.ac.uk
Pharmaceutical R&D process (PR&DP) has been deeply investigated by different streams of
literature; the interest is due to the strategic implication of the related decisions undertaken …